Asston Pharma Board Approves Auditors, Remuneration Hikes, AGM Details

Asston Pharmaceuticals Ltd announced key decisions from its Board of Directors meeting held on September 4, 2026. The board approved the appointment of M/s Yash A. Jain & Associates as Internal Auditors and M/s Panchal S K & Associates as Statutory Auditors. Additionally, the board resolved to recommend the re-appointment of Managing Director Mr. Ashish Narayan Sakalkar and approved proposed remuneration increases for Mr. Sakalkar, Mrs. Saili Jayaram More (Whole-time Director and CEO), and Mr. Sachin Chandrakant Badakh (Non-Executive Director), subject to member approval. The meeting also finalized the Board's Report for the financial year ended March 31, 2026, approved the notice for the 7th Annual General Meeting (AGM) scheduled for September 29, 2026, set September 22, 2026, as the cut-off date for e-voting, and appointed M/s Pragya & Associates as Scrutinizer for the AGM.